Coty Inc. — Fiscal 2023 Form 10-K
Reporting period: Fiscal year ended June 30, 2023. Although the request metadata says “2022 Q4,” this filing is an annual report for fiscal 2023; it also provides unaudited quarterly results, including the quarter ended June 30, 2023. Dollar amounts are in millions unless stated otherwise.
Business context
Coty sells fragrance, color cosmetics, and skin and body care products through its Prestige and Consumer Beauty segments in approximately 126 countries and territories. Prestige generated 61.6% of fiscal 2023 revenue and Consumer Beauty 38.4%. Coty retained a 25.9% stake in Wella, which is accounted for as an equity investment rather than consolidated operations.
Financial results and liquidity
| Metric | Fiscal 2023 | Fiscal 2022 |
|---|---|---|
| Net revenue | $5,554.1 | $5,304.4 |
| Gross profit / margin | $3,547.3 / 63.9% | $3,369.2 / 63.5% |
| Operating income / margin | $543.7 / 9.8% | $240.9 / 4.5% |
| Net income attributable to Coty Inc. | $508.2 | $259.5 |
| Diluted earnings per share | $0.57 | $0.08 |
| Adjusted operating income (non-GAAP) | $738.8 | $615.5 |
| Adjusted EBITDA (non-GAAP) | $972.8 | $905.3 |
| Cash from operating activities | $625.7 | $726.6 |
| Capital expenditures | $222.8 | $174.1 |
| Total debt, before unamortized fees and discounts | $4,281.6 | $4,498.5 |
| Cash and cash equivalents at year-end | $246.9 | $233.3 |
Revenue increased 5% reported, or 6% excluding the prior-year Russia comparison, with positive price and mix of 11% offset partly by 5% foreign-exchange headwinds. Reported sales rose 5% in both Prestige and Consumer Beauty. Adjusted operating margin rose to 13.3% from 11.6%; adjusted EBITDA margin increased to 17.5% from 17.1%. Cash from operations declined by $100.9, principally reflecting working-capital outflows, including inventory investment. Inventory increased to $853.4 from $661.5.
Current assets were $2,051.7 and current liabilities $2,736.8 at year-end. The filing reports $36.9 of restricted cash in addition to cash and cash equivalents. Coty said it was focused on deleveraging; common-stock dividends remained suspended, while Series B preferred dividends continued.
Material changes and unusual items
- Operating income more than doubled, supported by improved gross margin and lower SG&A as a percentage of revenue, alongside lower stock-based compensation and advertising/promotional expense relative to sales.
- GAAP net income was materially affected by non-operating fair-value items. Other income was $419.0, mainly reflecting a $230.0 unrealized gain on the Wella investment and a $196.9 unrealized gain on forward repurchase contracts. These items are not equivalent to recurring operating earnings.
- Coty recognized a $104.4 gain from early termination of the Lacoste fragrance license. It received approximately $93.9 in termination payments during fiscal 2023 and expected a further approximately $16.3 in fiscal 2024.
- Russia wind-down activity produced a $17.0 pre-tax gain in fiscal 2023, primarily from release of a bad-debt accrual after better-than-expected collections. Commercial activity was substantially completed, but legal-entity liquidation was expected to take an extended period.
- Fiscal 2022 included $31.4 of indefinite-lived intangible impairment charges and $45.9 of Russia-exit costs; no such impairment charge was recorded in fiscal 2023.
Outlook, risks and contingencies
Management expected fiscal 2024 net revenue growth in the mid-to-high single digits, excluding foreign exchange and the early termination of the Lacoste license. Coty reported sequential improvement in order fill rates during the second half of fiscal 2023 and expected to maintain or improve that progress into fiscal 2024’s first quarter. It cautioned that inflation, supply constraints and pricing actions may continue to affect performance.
Key risks include substantial leverage and variable interest-rate exposure; foreign-exchange volatility; consumer and retailer demand shifts; supply-chain and component availability; execution of the transformation and deleveraging plans; competition and reliance on long-term brand licenses; and cyber, regulatory and geopolitical risks. The company faces talc-related litigation and Brazilian tax assessments. It reported that current legal proceedings were not expected by management to have a material effect, while noting outcomes remain uncertain. Brazilian tax assessments remained contested; Coty had not recorded a loss because it did not consider one probable.
Subsequent to year-end, Coty entered a non-final agreement to sell 3.6% of Wella for $150.0, subject to due diligence and closing conditions, with proceeds intended for debt repayment. It also extended its revolving facility maturity to July 2028 and issued $750.0 of 6.625% senior secured notes due 2030, using net proceeds to repay Term B debt; it made a further euro-denominated Term B repayment in August 2023.
Important facts for investors to verify
- How much of earnings growth reflects sustainable operating improvement versus Wella valuation changes, forward-contract gains and the Lacoste termination gain.
- Progress converting higher revenue and adjusted earnings into operating cash flow, particularly after increased inventory and capital spending.
- Debt balances, interest costs, covenant headroom and the effect of post-year-end refinancing and repayments on maturities and liquidity.
- Whether the Wella stake sale closes on the disclosed terms and how proceeds are applied; separately assess the valuation of Coty’s remaining Wella investment.
- Whether fiscal 2024 guidance is achieved after foreign exchange, the Lacoste license exit, inflation and order-fill constraints.
- Developments in Brazil tax disputes, talc litigation, Russia liquidation, and the sensitivity of Max Factor’s trademark valuation; the auditor identified Max Factor valuation as a critical audit matter.